Biodexa Pharmaceuticals Plc
BDRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001643918
No open-market purchases or sales by Biodexa Pharmaceuticals Plc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $48.1K in total; no superinvestor holds it.
Holders of 5% or more of BDRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biodexa Pharmaceuticals Plc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G/A | 9.99%26.2K shares | 0.00 ppfrom 9.99% | Feb 14, 20235 filings | Aug 14, 2026 | SEC |
| Sabby Management, LLC | 13G | 9.90%217.6K shares | New | Jan 20, 20261 filing | Jan 20, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
23 Schedule 13D and 13G filings on Biodexa Pharmaceuticals Plc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202610:03 AM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%26.2K shares | 0.00 ppfrom 9.99% | Jun 30, 2026 | SEC |
| May 15, 202611:08 AM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%188.0K shares | 0.00 ppfrom 9.99% | Mar 31, 2026 | SEC |
| Feb 17, 20269:55 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%283.5K shares | – | Dec 31, 2025 | SEC |
| Jan 20, 20261:49 PM ET | Sabby Management, LLCand 2 others | 13G | 9.90%217.6K shares | New | Dec 31, 2025 | SEC |
| Nov 14, 20254:18 PM ET | C/M Capital Partners, LPand 7 others | 13G/A | 0.00%0 shares | −6.80 ppfrom 6.80%Below 5% | Jun 30, 2025 | SEC |
| May 28, 20255:59 PM ET | C/M Capital Partners, LPand 7 others | 13G | 6.80%1.75B shares | +6.80 ppfrom 0.00% | May 20, 2025 | SEC |
| Feb 18, 20254:30 PM ET | C/M Capital Partners, LPand 3 others | 13G | 0.00%0 shares | NewBelow 5% | Feb 10, 2025 | SEC |
| Nov 20, 2024 | Brio Capital Master Fund Ltd. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Iroquois Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | Bigger Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 7, 2024 | Cavalry Fund I LP | 13G/AOld format | – | – | – | SEC |
| Aug 8, 2024 | Iroquois Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Jul 23, 2024 | Brio Capital Master Fund Ltd. | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Ionic Ventures, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | CVI Investments, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Cavalry Fund I LP | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2024 | Bigger Capital, LLC | 13GOld format | – | New | – | SEC |
| Jan 8, 2024 | Mercer Street Global Opportunity Fund, LLC | 13GOld format | – | New | – | SEC |
| Dec 28, 2023 | Cavalry Fund I LP | 13GOld format | – | New | – | SEC |
| Mar 6, 2023 | Ionic Ventures, LLC | 13GOld format | – | New | – | SEC |
| Feb 21, 2023 | CVI Investments, Inc. | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Biodexa Pharmaceuticals Plc shares.
No Form 144 notices for Biodexa Pharmaceuticals Plc are on file.